Hillrom Overhead Patient Lift Recall Designated as a Class I Event
The U.S. Food and Drug Administration has categorized Hillrom’s recall of its Liko Multirall 200 overhead lift as Class I, its most serious level. Citing its potential for serious...
This Supplement was Advertised as “All-Natural.” The FDA Says that is not the Case, and that You Should Stop Taking it Now.
An over-the-counter male enhancement supplement sold under the brand name Adam’s Secret, which was advertised as being “all-natural”, is now being recalled as unapproved drugs by the FDA. The...
Heart Doctors 2 to 11 Times More Likely to Implant Devices made by Companies that Pay them, Study Finds
Doctors have always defended the industry payments that they receive as just compensation for sharing awareness and knowledge at conferences and for advising on products. Their prescription habits and...
Class I Recall: Medtronic Pump Implant Kits Delayed or Failed to Restart After the Pump was Stopped
A Class I recall, the most serious type of recall, has been issued for Medtronic HVAD Pump Implant Kits. “Use of these devices may cause serious injuries or death,”...
Recall Alert: A Medication Commonly Used to Treat Blood Clotting Disorders has been Recalled
Apotex Corp. has voluntarily pulled off Enoxaparin Sodium Injection, USP, from the market due to a packaging error which has resulted in some syringe barrels having an incorrect dosage...
How Much Does It Cost To Breathe?
A large majority of asthma inhalers remain expensive even with insurance. A rather complicated system of copay, manufacturer coupons, and federal programs might help some patients — not a...
Survey: More than 80 Percent of Docs hold Misconceptions about People with Disabilities
A recent survey of U.S. doctors finds that more than 80% of them hold the belief that people with disability have a worse quality of life as compared to...
Diving Deep Into 7 Women’s Experiences on how they Successfully Discontinued Antipsychotic Medication [New Study]
Discontinuation of antipsychotic medication can be extremely hard for mental health service users as it also comes with the risks of withdrawal and relapse. In a new study, psychologists...
A $24 Million Settlement in Whistleblower Complaints did not Stop Pharma from Using its Sketchy Nurse Ambassador Programs
In a recently published article in the Journal of the American Medical Association, authors Diana Mason and Tony Yang discussed how millions in settlement did not stop a pharmaceutical...
New Study finds Lower Opioid-Related Deaths in U.S. Counties with Legal Cannabis Dispensaries
U.S. counties where cannabis is legal had lower numbers of opioid-related deaths from 2014 to 2018, according to a recent study published in The BMJ. In the last year...